In one paragraphArticle in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
26 authors at 8 institutions in 4 countries.
Gustavo GoldmanFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Bloco Q, Universidade de São Paulo.ORCID 0000-0002-2986-350X Clara ValeroManchester Fungal Infection Group.
Camila PinzanFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Bloco Q, Universidade de São Paulo.
Patrícia de CastroFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo.
Kayleigh EarleManchester Fungal Infection Group, Division of Evolution, Infection, and Genomics, Faculty of Biology, Medicine and Health, University of Manchester.
Hong LiuThe Lundquist Institute for Biomedical Innovation.
Maria Augusta HortaFCFRP, Universidade de Sao Paulo.
Annica PschibulDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) and Institute of Microbiology, Friedrich Schiller University.
Derya CoemertDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) and Institute of Microbiology, Friedrich Schiller University.
Thorsten HeinekampDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) and Institute of Microbiology, Friedrich Schiller University.ORCID 0000-0001-9503-9634 Jacob SteenwykVanderbilt University.
Matthew MeadVanderbilt University.
Scott FillerDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
Nathalia da Rosa-GarzonFCFRP, Universidade de Sao Paulo.
Giuseppe PalmisanoICB-USP.
Ashraf IbrahimThe Lundquist Institute at Harbor-University of California Los Angeles Medical Center.ORCID 0000-0003-3787-8530 Thaila Does ReisUniversity of Sao Paulo.
Universidade de São Paulo · BRUniversity of Manchester · GBLeibniz Association · DEVanderbilt University · USLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEFoundation for Biomedical Research · USLos Angeles Medical Center · USUCLA Medical Center · US
Funding
Deciphering the phenotypic and genomic traits that underlie the evolution of pathogenicity differences among Aspergillus fumigatus and its close relativesR01AI153356 · NIAID · VANDERBILT UNIVERSITY · PI Antonis Rokas · 2022 to 2026
$3.5MNIAID NIH HHS R01 AI153356Wellcome Trust
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
asexual sporeAspergillus fumigatusconidiaconidial surface-associated proteomepathogenicitysurfome
Identifiers
PMID37790311
PMCPMC10543367
OpenAlexW4386826667
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390